M P Pereira1, S Mühl1, S Ständer2. 1. Kompetenzzentrum Chronischer Pruritus (KCP), Klinik für Hautkrankheiten, Universitätsklinikum Münster, Von-Esmarch-Str. 58, 48149, Münster, Deutschland. 2. Kompetenzzentrum Chronischer Pruritus (KCP), Klinik für Hautkrankheiten, Universitätsklinikum Münster, Von-Esmarch-Str. 58, 48149, Münster, Deutschland. sonja.staender@uni-muenster.de.
Abstract
BACKGROUND: Small fiber neuropathy arises from injury of small C and Aδ fibers and leads to pruritus as well as positive (pain, burning, tingling or stinging sensation) and negative neurological (numbness) symptoms. OBJECTIVES: To give an overview on small fiber neuropathy as a cause for chronic pruritus, the diagnostic approach to this condition, and therapeutic options. MATERIALS AND METHODS: A literature search using the terms "small fiber neuropathy", "pruritus", "itch", and "pain" was performed. RESULTS: Small fiber neuropathy is often associated with systemic diseases. However, it may occur without an underlying cause (idiopathic small fiber neuropathy). To identify small fiber neuropathy as the causal agent of pruritus, a detailed clinical history is essential. By measuring the intraepidermal nerve fiber density from skin biopsies at the sural nerve supplied region (lateral lower leg), the neurological impairment can be quantified. Often, dysfunction of a nerve fiber occurs after morphological changes ensue. Quantitative sensory testing allows the study of impaired function of these small fibers. Therapeutically, it is important to treat the underlying cause of the neuropathy. A symptomatic approach should be taken into account, when the cause cannot be treated. Topical capsaicin, as well as anticonvulsants and/or antidepressants, have been used with good results. CONCLUSION: Due to chronification processes, pruritus may persist even after treatment of the underlying cause. Therefore, early identification of small fiber neuropathy and immediate treatment of the cause is crucial for the success of the treatment.
BACKGROUND:Small fiber neuropathy arises from injury of small C and Aδ fibers and leads to pruritus as well as positive (pain, burning, tingling or stinging sensation) and negative neurological (numbness) symptoms. OBJECTIVES: To give an overview on small fiber neuropathy as a cause for chronic pruritus, the diagnostic approach to this condition, and therapeutic options. MATERIALS AND METHODS: A literature search using the terms "small fiber neuropathy", "pruritus", "itch", and "pain" was performed. RESULTS:Small fiber neuropathy is often associated with systemic diseases. However, it may occur without an underlying cause (idiopathic small fiber neuropathy). To identify small fiber neuropathy as the causal agent of pruritus, a detailed clinical history is essential. By measuring the intraepidermal nerve fiber density from skin biopsies at the sural nerve supplied region (lateral lower leg), the neurological impairment can be quantified. Often, dysfunction of a nerve fiber occurs after morphological changes ensue. Quantitative sensory testing allows the study of impaired function of these small fibers. Therapeutically, it is important to treat the underlying cause of the neuropathy. A symptomatic approach should be taken into account, when the cause cannot be treated. Topical capsaicin, as well as anticonvulsants and/or antidepressants, have been used with good results. CONCLUSION: Due to chronification processes, pruritus may persist even after treatment of the underlying cause. Therefore, early identification of small fiber neuropathy and immediate treatment of the cause is crucial for the success of the treatment.
Authors: G Lauria; S T Hsieh; O Johansson; W R Kennedy; J M Leger; S I Mellgren; M Nolano; I S J Merkies; M Polydefkis; A G Smith; C Sommer; J Valls-Solé Journal: Eur J Neurol Date: 2010-07 Impact factor: 6.089
Authors: B Schuhknecht; M Marziniak; A Wissel; N Q Phan; D Pappai; J Dangelmaier; D Metze; S Ständer Journal: Br J Dermatol Date: 2011-07 Impact factor: 9.302
Authors: Miroslav Misha Backonja; Nadine Attal; Ralf Baron; Didier Bouhassira; Mark Drangholt; Peter J Dyck; Robert R Edwards; Roy Freeman; Richard Gracely; Maija H Haanpaa; Per Hansson; Samar M Hatem; Elena K Krumova; Troels S Jensen; Christoph Maier; Gerard Mick; Andrew S Rice; Roman Rolke; Rolf-Detlef Treede; Jordi Serra; Thomas Toelle; Valeri Tugnoli; David Walk; Mark S Walalce; Mark Ware; David Yarnitsky; Dan Ziegler Journal: Pain Date: 2013-06-03 Impact factor: 6.961
Authors: R Rolke; R Baron; C Maier; T R Tölle; - D R Treede; A Beyer; A Binder; N Birbaumer; F Birklein; I C Bötefür; S Braune; H Flor; V Huge; R Klug; G B Landwehrmeyer; W Magerl; C Maihöfner; C Rolko; C Schaub; A Scherens; T Sprenger; M Valet; B Wasserka Journal: Pain Date: 2006-05-11 Impact factor: 6.961
Authors: R A Malik; P Kallinikos; C A Abbott; C H M van Schie; P Morgan; N Efron; A J M Boulton Journal: Diabetologia Date: 2003-05-09 Impact factor: 10.122
Authors: Mitra Tavakoli; Cristian Quattrini; Caroline Abbott; Panagiotis Kallinikos; Andrew Marshall; Joanne Finnigan; Philip Morgan; Nathan Efron; Andrew J M Boulton; Rayaz A Malik Journal: Diabetes Care Date: 2010-04-30 Impact factor: 19.112
Authors: Omar Asghar; Ioannis N Petropoulos; Uazman Alam; Wendy Jones; Maria Jeziorska; Andrew Marshall; Georgios Ponirakis; Hassan Fadavi; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik Journal: Diabetes Care Date: 2014-06-26 Impact factor: 19.112